Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 195   

Articles published

AZN 3,745.27 +22.27 (0.60%)
price chart
AstraZeneca plc Rating Reiterated by Beaufort Securities (AZN)
AstraZeneca plc (LON:AZN) opened at 3883.50 on Monday. AstraZeneca plc has a 52 week low of GBX 3028.50 and a 52 week high of GBX 4115.00.
AstraZeneca plc Stock Rating Reaffirmed by Beaufort Securities (AZN)  Mideast Time
Related articles »  
AstraZeneca plc: AstraZeneca and MRC enter strategic collaboration to create ...
AstraZeneca and the Medical Research Council (MRC) today announced that they have entered into a groundbreaking collaboration aimed at better understanding the mechanisms of human disease.
AstraZeneca share price: Pharma giant strikes deal with state-funded MRC  iNVEZZ
Related articles »  
Beaufort Securities Breakfast Today AstraZeneca, Balfour Beatty, Direct Line ...
Beaufort Securities Breakfast Today AstraZeneca, Balfour Beatty, Direct Line and Starcom Plc. By Beaufort Securities March 24 2014, 8:35am.
Related articles »  
AstraZeneca plc Given Reduce Rating at Swedbank (AZN)
AstraZeneca plc logo AstraZeneca plc (LON:AZN)'s stock had its �reduce� rating reaffirmed by stock analysts at Swedbank in a report issued on Wednesday, American Banking News reports.
Related articles »  
Healthcare Stocks to Watch: TrovaGene (NASDAQ:TROV), AstraZeneca plc ...
AstraZeneca plc (ADR) (NYSE:AZN) shares were up about 1% in late Monday trading after the drug-maker earlier today reported progress in a clinical trial of its ticagrelor drug candidate in patients with high-risk cardiovascular disease, completing ...
Related articles »  
AstraZeneca plc Receives Reduce Rating from Swedbank (AZN)
AstraZeneca plc logo Swedbank restated their reduce rating on shares of AstraZeneca plc (LON:AZN) in a report released on Wednesday, AnalystRatingsNetwork reports.
AstraZeneca plc Lowered to Underweight at Morgan Stanley (AZN)
AstraZeneca plc logo AstraZeneca plc (NYSE:AZN) was downgraded by research analysts at Morgan Stanley to an �underweight� rating in a report released on Thursday, AmericanBankingNews.
Related articles »  
Pfizer, AstraZeneca, and Novartis Reveal New Business Developments
With small cap biotech companies flooding the news, Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), and Novartis AG (ADR) (NVS) revealed developments in their businesses.
Related articles »  
AstraZeneca plc's "Reduce" Rating Reaffirmed at Swedbank (AZN)
AstraZeneca plc logo AstraZeneca plc (LON:AZN)'s stock had its �reduce� rating restated by investment analysts at Swedbank in a note issued to investors on Wednesday, Analyst Ratings Network.
AstraZeneca plc Rating Increased to Hold at Panmure Gordon (AZN)
AstraZeneca plc (NYSE:AZN) last released its earnings data on Thursday, February 6th. The company reported $1.23 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.22 by $0.01.
Related articles »